Jump to main content
Jump to site search

Issue 49, 2016, Issue in Progress
Previous Article Next Article

Advanced generation of paeonol-phenylsufonyl derivatives as potential anti-HBV agents

Author affiliations

Abstract

Hepatitis B virus (HBV) infection causes serious liver diseases, and the development of effective drugs for chronic hepatitis B treatment remains an important step towards the eradication of HBV worldwide. Recently, our group designed paeonol-phenylsulfonyl derivatives and found that the compound 2-acetyl-5-methoxyphenyl 4-methoxybenzenesulfonate (6f) had the most potent antiviral effect against HBV, with an IC50 value of 0.36 μM and a high selectivity index (SI; TC50/IC50) of 47.75. In this research, we modified compound 6f with a 2-aminothiazole scaffold and generated 13 novel paeonol derivatives by utilizing various benzoyl and acyl chlorides. Among this new generation, compound 2-(2-benzamidothiazol-4-yl)-5-methoxyphenyl 4-methoxybenzenesulfonate (8a) showed the highest SI value of 59.14 which exceeds those of compound 6f and lamivudine (3TC), a commercially available antiviral drug. Hence, we believe that our studies may offer some useful information for the development of antiviral medicines.

Graphical abstract: Advanced generation of paeonol-phenylsufonyl derivatives as potential anti-HBV agents

Back to tab navigation

Supplementary files

Article information


Submitted
08 Mar 2016
Accepted
08 Apr 2016
First published
18 Apr 2016

RSC Adv., 2016,6, 43556-43562
Article type
Paper

Advanced generation of paeonol-phenylsufonyl derivatives as potential anti-HBV agents

Y. P. Huang, H. P. Shih, Y. C. Liang, H. H. Lin, M. C. Lin, C. W. Chen, T. J. Huang, Y. C. Kuo, C. C. Han and M. H. Hsu, RSC Adv., 2016, 6, 43556
DOI: 10.1039/C6RA06119B

Social activity

Search articles by author

Spotlight

Advertisements